Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,816

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

Open access
Adler, Amanda I., Stevens, Richard J., Manley, Sue E., Bilous, Rudy W., Cull, Carole A., Holman, Rury R., UKPDS Group·2003·Kidney International
DOI 10.1046/j.1523-1755.2003.00712.x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1523-1755.2003.00712.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 44

  1. Brancati, 1997, Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial, JAMA, 278, 2069, 10.1001/jama.1997.03550230045035 · doi:10.1001/jama.1997.03550230045035 · Paper page
  2. Schaubel, 1999, End-stage renal disease in Canada: Prevalence projections to 2005, Can Med Assoc J, 160, 1557
  3. US Renal Data System, 2000, Excerpts from the USRDS Annual Data Report, Am J Kidney Dis, 36, S1
  4. Parving, 1996, Initiation and progression of diabetic nephropathy, N Engl J Med, 335, 1682, 10.1056/NEJM199611283352212 · DOI
  5. Gall, 1997, Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study, BMJ, 314, 783, 10.1136/bmj.314.7083.783 · DOI · Paper page
  6. Forsblom, 1998, Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM, Diabetes Care, 21, 1932, 10.2337/diacare.21.11.1932 · DOI
  7. Ravid, 1998, Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia, Arch Intern Med, 158, 998, 10.1001/archinte.158.9.998 · DOI · Paper page
  8. Ballard, 1988, Epidemiology of persistent proteinuria in type II diabetes mellitus; Population-based study in Rochester, Minnesota, Diabetes, 37, 405, 10.2337/diab.37.4.405 · DOI · Paper page
  9. Fagot-Campagna, 1998, Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: The Strong Heart Study, Diabetologia, 41, 1002, 10.1007/s001250051023 · DOI
  10. Lee, 1993, A follow-up study of diabetic Oklahoma Indians: Mortality and causes of death, Diabetes Care, 16, 300, 10.2337/diacare.16.1.300 · doi:10.2337/diacare.16.1.300
  11. Nelson, 1993, Diabetic kidney disease in Pima Indians, Diabetes Care, 16, 335, 10.2337/diacare.16.1.335 · doi:10.2337/diacare.16.1.335
  12. Nelson, 1996, Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus, N Engl J Med, 22, 1636, 10.1056/NEJM199611283352203 · DOI · Paper page
  13. Viswanathan, 2000, Evaluation of a simple, random urine test for prospective analysis of proteinuria in Type 2 diabetes: A six year follow-up study, Diabetes Res Clin Pract, 49, 143, 10.1016/S0168-8227(00)00153-4 · doi:10.1016/s0168-8227(00)00153-4
  14. Nosadini, 2000, Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate, Diabetes, 49, 476, 10.2337/diabetes.49.3.476 · DOI · Paper page
  15. UKPDS Group, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
  16. UKPDS Group, 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39), BMJ, 317, 713, 10.1136/bmj.317.7160.713 · DOI · Paper page
  17. UKPDS Group, 1994, UK Prospective Diabetes Study XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects, Diabetic Med, 11, 534, 10.1111/j.1464-5491.1994.tb02032.x · DOI
  18. UKPDS Group, 1992, UK Prospective Diabetes Study IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy, Diabetologia, 36, 835
  19. Manley, 1992, Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20°C, Clin Chem, 38, 2294, 10.1093/clinchem/38.11.2294 · DOI
  20. UKPDS Group, 1993, UK Prospective Diabetes Study X. Urinary albumin excretion over 3 years in diet-treated Type 2 (non-insulin-dependent diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia, Diabetologia, 36, 1021
  21. UKPDS Group, 1991, UK Prospective Diabetes Study VIII: Study design, progress and performance, Diabetologia, 34, 877, 10.1007/BF00400195 · DOI · Paper page
  22. Mantel, 1961, Chi-Square tests with one degree of freedom; Extensions of the Mantel-Haenszel procedure, J Am Stat Assoc, 58, 690
  23. Sonnenberg, 1993, Markov models in medical decision making: A practical guide, Med Decis Making, 13, 322, 10.1177/0272989X9301300409 · DOI · Paper page
  24. Mattock, 1998, Microalbuminuria and coronary heart disease in NIDDM: An incidence study, Diabetes, 47, 1786, 10.2337/diabetes.47.11.1786 · DOI · Paper page
  25. Khunti, 1999, Quality of care of patients with diabetes: Collation of data from multi-practice audits of diabetes in primary care, Fam Pract, 16, 54, 10.1093/fampra/16.1.54 · doi:10.1093/fampra/16.1.54
  26. Harris, 2001, Frequency of blood glucose monitoring in relation to glycemia control in patients with type 2 diabetes, Diabetes Care, 24, 979, 10.2337/diacare.24.6.979 · DOI · Paper page
  27. Klein, 1989, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more, Arch Ophthalmol, 107, 244, 10.1001/archopht.1989.01070010250031 · DOI · Paper page
  28. Valmadrid, 2000, The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus, Arch Intern Med, 160, 1093, 10.1001/archinte.160.8.1093 · DOI · Paper page
  29. Mogensen, 1984, Microalbuminuria predicts clinical preteinuria and early mortality in maturity-onset diabetes, N Engl J Med, 310, 356, 10.1056/NEJM198402093100605 · DOI · Paper page
  30. Brancati, 1995, Epidemiology and prevention of diabetic nephropathy, Curr Opin Nephrol Hypertens, 4, 223, 10.1097/00041552-199505000-00004 · DOI
  31. Lee, 1994, Incidence of renal failure in NIDDM, Diabetes, 43, 572, 10.2337/diab.43.4.572 · DOI
  32. McCrary, 1981, Diabetic nephropathy: Natural course, survivorship and therapy, Am J Nephrol, 1, 206, 10.1159/000166541 · doi:10.1159/000166541
  33. Fagot-Campagna, 2000, Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective, J Pediatr, 136, 664, 10.1067/mpd.2000.105141 · DOI · Paper page
  34. Fleischmann, 1999, Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients, Kidney Int, 55, 1560, 10.1046/j.1523-1755.1999.00389.x · DOI · Paper page
  35. Remuzzi, 1993, Slowing the progression of diabetic nephropathy, N Engl J Med, 329, 1496, 10.1056/NEJM199311113292012 · doi:10.1056/nejm199311113292012
  36. Charra, 2001, Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes, Adv Ren Replace Ther, 8, 42, 10.1053/jarr.2001.21708 · DOI
  37. Golan, 1999, The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors, Ann Intern Med, 131, 660, 10.7326/0003-4819-131-9-199911020-00005 · DOI · Paper page
  38. Caro, 2000, Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes, Clin Ther, 22, 116, 10.1016/S0149-2918(00)87983-7 · doi:10.1016/s0149-2918(00)87983-7
  39. Eastman, 1997, Model of complications of NIDDM. I. Model construction and assumptions, Diabetes Care, 20, 725, 10.2337/diacare.20.5.725 · DOI · Paper page
  40. Dinneen, 1997, The association between microalbuminuria and mortality in non-insulin dependent diabetes mellitus: A systematic overview of the literature, Arch Intern Med, 157, 1413, 10.1001/archinte.1997.00440340025002 · DOI · Paper page
  41. Baigent, 2000, Premature cardiovascular disease in chronic renal failure, Lancet, 356, 147, 10.1016/S0140-6736(00)02456-9 · DOI · Paper page
  42. Mann, 2001, Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial, Ann Intern Med, 134, 629, 10.7326/0003-4819-134-8-200104170-00007 · DOI · Paper page
  43. Mogensen, 1995, Prevention of diabetic renal disease with special reference to microalbuminuria, Lancet, 346, 1080, 10.1016/S0140-6736(95)91747-0 · DOI · Paper page
  44. American Diabetes Association, 2001, Position Statement Diabetic Nephropathy, Diabetes Care, 24, S69

Cited by

See all 1,816

Metadata

Authors
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group
Venue
Kidney International
Publisher
Elsevier BV
Published
2003-01
Volume
63
Issue
1
Pages
225-232
ISSN
0085-2538 (ISSN-L)
DOI
10.1046/j.1523-1755.2003.00712.x
OpenAlex
W1985941010
Cited by
1,816
References
10
FWCI
29.82
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). https://app.cochat.ai/papers/10.1046/j.1523-1755.2003.00712.x
The paper
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group. (2003). Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International. https://doi.org/10.1046/j.1523-1755.2003.00712.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.